YONO Health Inc.

What YONO Health Inc. does

YONO Health Inc. is a private, for-profit health technology company headquartered in Santa Clara, California, founded in 2014. The company is positioned as the developer of the "first in-ear ovulation predictor," indicating a consumer health wearable focused on fertility tracking through an in-ear biosensing form factor rather than the more common wrist-worn or skin-patch modalities. The product targets women seeking to predict ovulation, suggesting a direct-to-consumer go-to-market in the women's health and fertility space.

Operationally, YONO Health is a micro-cap entity with 1-10 employees, a single funding round on record (June 2015, with no disclosed capital raised), and no publicly available information on pricing, distribution, customers, or revenue model. The firmographic record provides only a website URL (yonolabs.com) and a brief functional description; technology stack, proprietary features, partnerships, regulatory milestones, and management details are absent from the source data. No app store listings, certifications, patents, or partnership disclosures are documented.

The business model is not disclosed in the input. By inference from the product category, plausible monetization paths include direct hardware sales, subscription-linked cycle insights, and ancillary data services, but none are confirmed by the source material. Overall, the available evidence describes an early-stage, minimally capitalized health hardware startup whose commercial maturity, regulatory pathway status, and current operating scale cannot be substantiated from the data provided.

Name

YONO Health Inc.

Website

https://yonolabs.com

Company type

Private

Founded year

2014

Headcount range

1–10 employees

Short description

YONO Health Inc. is a Santa Clara-based health technology company developing what it describes as the first in-ear ovulation predictor, a wearable device aimed at women seeking to forecast fertility windows.

Ownership category

akta.pro rank

Product category

Fertility Tracking Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Fertility & Ovulation Products (OTC) (CRABAIAK)

Keywords

• In-ear ovulation predictor
• Fertility tracking device
• Wearable health sensor
• Reproductive health technology
• Ovulation prediction device

Headquarters

HQ city

Santa Clara

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Core offering

YONO Health Inc. develops and sells the first in-ear ovulation predictor, a small wearable device inserted into the ear that captures physiological signals used to forecast ovulation. The product is designed for individual women and couples seeking to identify their fertile window for conception.

Differentiator

Problem solved

Functional benefit

Products and services

• In-ear Ovulation Predictor A compact wearable device inserted in the ear that captures physiological biosignals and uses an ovulation-prediction algorithm to identify the user's fertile window. Designed for individual women and couples trying to conceive who want continuous, passive fertility monitoring without urine strips or oral thermometers.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights2 records

Direct peers

• Natural Cycles: Natural Cycles is an FDA-cleared fertility tracking app, originally paired with a basal body temperature thermometer. Comparable as a digital ovulation/fertility prediction solution competing for the same end consumer.
• Ava Science (Ava bracelet): Ava sells a fertility-tracking wearable bracelet with an accompanying app. Highly comparable as a consumer hardware device that tracks physiological signals for ovulation prediction, targeting the same trying-to-conceive customer.
• Mira Fertility: Mira sells an at-home hormone monitoring system for ovulation and fertility. Comparable as a connected consumer device that quantitatively predicts ovulation using a different sensing modality (urine hormone assay) than YONO's in-ear approach.

Broad incumbents

• Kindbody: Kindbody is a US fertility clinic and benefits platform offering diagnostics and treatment. Comparable as a broader women's fertility services player that increasingly bundles consumer tracking hardware/diagnostics, representing both a competitor and a potential channel partner.
• First Response (Church & Dwight): First Response is a leading OTC ovulation and pregnancy test brand owned by Church & Dwight. Comparable as a mass-market ovulation predictor brand that competes for the same end-customer use case.
• Clearblue (SPD Swiss Precision Diagnostics): Clearblue is the dominant consumer ovulation and pregnancy test brand worldwide (SPD, joint venture of Procter & Gamble and Alere/Abbott). Highly comparable as the incumbent OTC ovulation prediction product that any consumer in-ear competitor must displace.

Regional players

• Modern Fertility (Ro): Modern Fertility (acquired by Ro) sells at-home hormone tests and a fertility subscription service primarily in the US. Comparable as a women's health consumer brand competing for the same end-customer fertility journey.

Emerging players

• Proov: Proov markets at-home PdG (progesterone metabolite) urine tests aimed at confirming ovulation. Comparable as a newer direct-to-consumer ovulation diagnostics brand in the same consumer segment.
• Oura: Oura sells a smart ring that tracks sleep, recovery, and physiological signals including temperature trends relevant to cycle tracking. Comparable as a wearable consumer health device using novel form-factor sensing — adjacent technology and overlapping female-health use case.
• Tempdrop: Tempdrop is a wearable overnight basal body temperature sensor used for cycle and ovulation charting. Comparable as a wearable consumer device aimed at the same ovulation-tracking use case via continuous physiological sensing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights3 records

Customer concentration

• Xx.com/yonolabs
• Facebookfacebook.com/yonolabs
• LinkedInlinkedin.com/company/yono-health-inc-

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about YONO Health Inc.